Overview
AORT market data
Price History
AORT price chart
Valuation & Profitability
- P/E (TTM)
- 91.08 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- 41.32 P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.25 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.40 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $19.16 – $48.25 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- $42.88 Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Alpha Vantage OVERVIEW · market cap $1.1B · P/B 2.74 · P/S 2.41.
Company news
Needham Reiterates Buy on Artivion, Maintains $44 Price TargetBenzinga · Jul 20, 2026, 10:12 AM
Artivion Seeks To Tap $150 Million US Market Opportunity With FDA ApprovalBenzinga · Jun 29, 2026, 5:45 PM
Artivion Says FDA Approves Premarket Approval Application For AMDS Hybrid ProsthesisBenzinga · Jun 29, 2026, 11:20 AM
8-K filing — ARTIVION, INC. (AORT)SEC EDGAR · May 18, 2026, 11:06 AM